3rd DNA Process Development and Manufacturing Summit

Cutting-edge breakthroughs in DNA production, from high-yield plasmid manufacturing to next-generation cell-free platforms, are transforming how biopharma develops advanced vaccines and nucleic acid-based therapeutics. Organizations across the space are accelerating investment in technologies that enhance upstream fermentation efficiency, streamline downstream purification, and strengthen CMC frameworks for rapid, compliant scale-up.

The 3rd DNA Process Development and Manufacturing Summit arrives at this pivotal moment as the only meeting entirely focused on DNA process development and manufacturing, designed to immerse you in the applied learnings needed to drive the next wave of innovation in DNA production.

Delve into the latest approaches for optimizing plasmid design, boosting fermentation productivity, advancing purification, reducing impurities, building robust analytical and QC strategies, and aligning regulatory expectations from early development through commercial production. Explore how to unlock reproducibility, scalability, and cost-efficient GMP-grade DNA.

Unite with industry leaders such as Sanofi, Pfizer, GSK, Boehringer Ingelheim, GreenLight Biosciences, HDT Bio, and others, as well as innovative emerging players advancing new DNA formats and manufacturing technologies.

This is your premier meeting dedicated to exploring the full DNA manufacturing lifecycle, from upstream to downstream, process development to scale-up, and quality to regulatory alignment. Walk away with actionable insights, practical solutions, and new strategic partnerships to accelerate the delivery of high-quality DNA for tomorrow's vaccines and therapies.

URLs:
Website: https://go.evvnt.com/3378728-0?pid=2874
Tickets: https://go.evvnt.com/3378728-3?pid=2874

Category: Conferences | Health

Prices:
Conference + Workshop Day - Drug Developer - OTD: USD 4397.00,
Conference Only - Drug Developer - OTD: USD 3099.00,
Conference + Workshop Day - Academic Pricing - OTD: USD 3797.00,
Conference Only - Academic Pricing - OTD: USD 2699.00,
Conference + Workshop Day - Service Provider Pricing - OTD: USD 5297.00,
Conference Only - Service Provider Pricing - OTD: USD 3799.00

Speakers: Cecile Brocard, Director and Head - Downstream Development, Boehringer Ingelheim, François de Mets, Principal Scientist, GlaxoSmithKline, Imran Hussain, Scientist - Nucleic Acids Vaccines, GSK, Haitao Zhang, Senior Principal Scientist and Group Leader, Pfizer, Mickey Vande Voorde, Senior Associate Scientist - Upstream Process Development, Pfizer, Maitreya Das, mRNA Scientist - High- Throughput DNA and Plasmid Production, Sanofi, Christel Logez, Unit head CMC DNA Process Development / mRNA center, Sanofi, Nicolas Chaudet, Head - Local Drug Substance and Process Development mRNA and pDNA, Sanofi, Andrew Passarotti, Associate Director - Raw Materials Planning, Beam Therapeutics, Jason Roth, Project, Sid Leader, Ceva Animal Health, Andreas Bauer, Senior Scientist - Process Development pDNA and RNA Production, CureVac SE, Yang Claire, Zeng Founder and CEO, DoriNano, Naren Sekar, Senior Scientist and Head - Process Development, GreenLight BioSciences, Jesse Erasmus, Director - Virology, HDT Bio, Jeff Sparks, Senior Director, Process Development and Clinical Manufacturing, IMUNON, Kok Seong, Lim Independent Cell and Gene Therapy CMC Expert, Independent Expert, Sing Fai Wai, Independent Expert, Salomé Magalhães, Research Fellow - Vaccine Bioprocessing, University College London - UCL